FDA Guidance on Responding to Unsolicited Requests for Off-Label Information
pharma-mkting.comTwo days after Christmas, on December 27, 2011, while most of us were still on vacation, the FDA quietly issued “Guidance for Industry Responding to Unsolicited Requests for Off-Label Information About Prescription Drugs and Medical…
RT @pharmaguy: FDA Guidance on Responding to Unsolicited Requests for Off-Label Information. Free PMN article: http://flip.it/IukwS http://flip.it/GpdGc
Related articles
- Big Pharma and unfiltered speech: A dangerous prescription (features.blogs.fortune.cnn.com)
- Drug Approvals Reach 15-Year High on Smoother FDA Reviews – Bloomberg (bloomberg.com)
- FDA approved 39 new drugs in 2012, none from Houston (bizjournals.com)
- Pharma Best Practices: in Black and White, not Shades of Gray (medmeme.com)
- Social Media Guidance Countdown Continues: 576, 575, 574 . . . (druganddevicelaw.blogspot.com)
- Pharma Marketing Blog: The Year 2012 in Images (slideshare.net)
- Case Study: Pharma and Blogging (medmeme.com)
